Itch in patients with cutaneous T-cell lymphoma as a quality of life indicatorCapsule Summary
Background: Cutaneous T-cell lymphoma (CTCL) is a chronic and progressive disease that has a major impact on quality of life (QoL). Objectives: To describe the impact of the different stages of disease in patients with classical mycosis fungoides, folliculotropic mycosis fungoides, and Sézary syndro...
Main Authors: | Rosanne Ottevanger, MD, Sylvia van Beugen, MSc, PhD, Andrea W.M. Evers, MSc, PhD, Rein Willemze, MD, PhD, Maarten H. Vermeer, MD, PhD, Koen D. Quint, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | JAAD International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666328722000992 |
Similar Items
-
Reply to Correspondence to “Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator”
by: Rosanne Ottevanger, MD, et al.
Published: (2023-03-01) -
Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider
by: Rosanne Ottevanger, et al.
Published: (2022-12-01) -
Evaluation of Quality of Life and Treatment Satisfaction in Newly Diagnosed Cutaneous T-Cell Lymphoma Patients
by: Rosanne Ottevanger, et al.
Published: (2024-02-01) -
Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
by: Janika Gosmann, et al.
Published: (2023-10-01) -
Clinical outcomes in a cohort of patients with cutaneous T-cell lymphoma and COVID-19
by: John S. Runge, PhD, et al.
Published: (2022-09-01)